Is melatonin indicated for an adult with insomnia related to circadian rhythm disruption, and what dosing and contraindications should be considered?

Melatonin for Sleep: Evidence-Based Recommendations

The American Academy of Sleep Medicine explicitly recommends AGAINST using melatonin for chronic insomnia in adults, but supports its use for circadian rhythm disorders (such as delayed sleep-wake phase disorder) at doses of 3-5 mg taken 1.5-2 hours before desired bedtime. 1

Critical Distinction: Insomnia vs. Circadian Rhythm Disorders

For Primary Chronic Insomnia (NOT Recommended)

• Do not use melatonin as first-line therapy for sleep onset or sleep maintenance insomnia in adults. 1
• The evidence shows only minimal benefit: sleep latency reduction of approximately 9 minutes compared to placebo, with very low quality evidence and benefits roughly equal to harms. 1
• Instead, consider FDA-approved hypnotics (zolpidem 10 mg, eszopiclone 2-3 mg) or cognitive behavioral therapy for insomnia (CBT-I) as first-line treatments. 2

For Circadian Rhythm Disruption (Recommended)

This is where melatonin has proven efficacy and guideline support:

Delayed Sleep-Wake Phase Disorder (DSWPD) in Adults

• Start with 3-5 mg immediate-release melatonin taken between 19:00-21:00 (approximately 1.5-2 hours before desired bedtime) for at least 28 days. 1, 2
• Evidence shows reduction in sleep latency by 38-44 minutes and increase in total sleep time by 56 minutes in non-depressed adults. 1
• This timing is critical—taking melatonin at the wrong time can worsen circadian misalignment. 2

DSWPD in Children Without Comorbidities

• Use weight-based dosing: 0.15 mg/kg administered 1.5-2 hours before habitual bedtime for minimum 6 nights. 1, 2
• For a 30 kg child, this equals approximately 4.5 mg. 1

DSWPD in Children With Psychiatric Comorbidities

• Give 3 mg if <40 kg or 5 mg if ≥40 kg, administered at 18:00-19:00 for 4 weeks. 2

Non-24-Hour Sleep-Wake Rhythm Disorder (Blind Patients)

• Use 0.5-10 mg (typically start with 5 mg) at 21:00 or 1 hour before preferred bedtime for 26-81 days. 2

Dosing Algorithm

Step 1: Confirm diagnosis—is this circadian rhythm disorder or primary insomnia?

• If primary insomnia → Do not use melatonin 1
• If circadian rhythm disorder → proceed to Step 2

Step 2: Determine appropriate dose based on population:

• Adults with DSWPD: 3-5 mg immediate-release 1, 2
• Children without comorbidities: 0.15 mg/kg 1, 2
• Children with psychiatric comorbidities: 3 mg (<40 kg) or 5 mg (≥40 kg) 2
• Elderly (≥55 years): 2 mg prolonged-release may provide modest benefit, though evidence is low quality 1

Step 3: Time administration correctly:

• 1.5-2 hours before desired bedtime (typically 19:00-21:00 for 21:00-23:00 bedtime) 1, 2, 3
• Never administer in morning or afternoon—this worsens circadian misalignment 3

Step 4: Assess response after 1-2 weeks:

• If ineffective and no adverse effects, may increase by 3 mg increments up to maximum 15 mg 2, 4
• Do not exceed 10 mg routinely—higher doses cause receptor desensitization without added benefit 2, 4

Duration of Treatment

• For chronic insomnia: Maximum 3-4 months (though not recommended as first-line) 2, 3
• For circadian rhythm disorders: May be used long-term as ongoing chronobiotic therapy 1, 2
• Reassess need every 3-6 months with periodic attempts to reduce frequency or dose 2

Critical Safety Warnings and Contraindications

Absolute Cautions

• Warfarin users: Potential drug interactions reported to WHO—use with extreme caution and monitor INR closely 2, 3, 4
• Epilepsy: Case reports suggest possible seizure aggravation—exercise caution 2, 3, 4
• Elderly with dementia and irregular sleep-wake rhythm disorder: Avoid—evidence shows potential harm with detrimental effects on mood and daytime functioning 2, 3

Drug Interactions

• Fluvoxamine: Markedly increases melatonin levels via CYP1A2 inhibition—avoid combination 3
• Multiple serotonergic agents: When combined with SSRIs, SNRIs, TCAs, tramadol—start low, titrate slowly, monitor for serotonin syndrome 3
• CNS depressants and alcohol: Additive sedation and impaired psychomotor function 3

Common Adverse Effects

• Daytime somnolence (1.66% incidence) 2, 3
• Headache (0.74% incidence) 2, 3
• Morning grogginess—more common with higher doses due to half-life extending into morning 2
• Gastrointestinal upset—more frequent at higher doses 2

Product Quality Concerns

Critical pitfall: Melatonin is regulated as a dietary supplement in the U.S., NOT as a medication, raising significant concerns about purity and reliability of stated doses. 2, 3, 4

• Choose United States Pharmacopeial Convention (USP) Verified formulations for reliable dosing and purity. 2, 3
• Different brands may have variable efficacy due to inconsistent formulation quality. 3

Formulation Selection

• Immediate-release melatonin is more effective than prolonged-release for sleep onset in DSWPD. 2
• Prolonged-release 2 mg may be considered for elderly patients (≥55 years) with sleep maintenance issues, though evidence is low quality. 1, 2

Common Pitfalls to Avoid

1. Using melatonin for primary insomnia instead of circadian disorders—this contradicts AASM guidelines 1
2. Wrong timing—taking melatonin in morning/afternoon worsens circadian misalignment 2, 3
3. Excessive dosing—doses >10 mg cause receptor desensitization without benefit 2, 4
4. Ignoring product quality—non-USP verified products may contain unreliable doses 2, 3, 4
5. Long-term use for insomnia—insufficient safety data beyond 3-4 months for this indication 2, 3

Realistic Expectations

When used appropriately for circadian rhythm disorders:

• Sleep latency reduction: 28-42 minutes 2, 4
• Total sleep time increase: 1.8-2.6 hours in responsive populations 2, 4
• These benefits apply primarily to circadian disorders, NOT primary insomnia 1